HEMO CHINA at CSA and TISC 2021
July 10, 2021
HEMO CHINA was present at CSA & TISC 2021, this year’s edition of the Annual Scientific Session of Chinese Stroke Association (CSA) and Tiantan International
Innovative interventional solutions addressing neurovascular and peripheral diseases
We have built a suite of innovative interventional medical devices targeting neuro-vascular diseases in China and the broader Asia-Pacific region. Our comprehensive portfolio of neuro-interventional medical devices covers the ischemic stroke, hemorrhagic stroke and neuro access fields.
Other than being a top notch neuro medical device manufacturer with ISO 13485, Certified Class 10K Cleanroom, we also provide the following services:
Contact us at enquire@hemocorp.com for our services.
Our Company's Devices
Mechanical Thrombectomy Devices
Our Company's Mechanical Thrombectomy Devices offers neuro-interventionalists in a differentiated tool for the treatment of acute ischemic stroke.
Our Mechanical Thrombectomy device consist of Aspiration Catheter and intravascular thrombectomy device.
Click here to find out more.
Our Mechanical Thrombectomy device consist of Aspiration Catheter and intravascular thrombectomy device.
Click here to find out more.
Access Device
Our Company's Access Devices provides guiding access for other neuro interventional devices in the treatment of acute ischemic stroke, intracranial atherosclerosis and hemorrhagic stroke
.
Our Access Device consist of Access Catheter, Balloon Guiding Catheter, Micro Catheter and Guiding Catheter.
Click here to find out more.
Our Access Device consist of Access Catheter, Balloon Guiding Catheter, Micro Catheter and Guiding Catheter.
Click here to find out more.
Dilation Device
Our Company's Dilation Device offers neuro-interventionalists in a differentiated tool for the treatment of intracranial stenosis.
Our Dilation Device Consist of Balloon Dilation Catheter and Neuro Dilation Catheter(OTW).
Click here to find out more.
Our Dilation Device Consist of Balloon Dilation Catheter and Neuro Dilation Catheter(OTW).
Click here to find out more.
Our Latest News
HEMO Receives NMPA Approval for Afentta™ Aspiration Catheter
May 24, 2021
HEMO BIOENGINEERING LIMITED (“HEMO”), a Singapore-based medical device company with a focus on treating stroke patients, is pleased to announce that its Afentta™ intracranial thrombectomy
HEMO CHINA Recognised as 18th Top Medical Device Company in Future Medical VB100 List
April 19, 2021
Big congratulations go to our HEMO CHINA subsidiary for being recognized as the 18th Top Medical Device Company in this year’s prestigious Future Healthcare VB100
